Smith & Nephew plc (SNN) Stock Price Today
Aura AI Summary
Key Stats
- $12.69BMARKET_CAP
- -VOLUME
- HealthSECTOR
- $38.70FIFTY_TWO_WEEK_HIGH
- $28.73FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $15.46BENTERPRISE_VALUE
- 2.59%DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track Smith & Nephew plc (SNN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Smith & Nephew plc has traded between a low of $28.73 and a high of $38.7, highlighting its annual price range. Buy and sell Smith & Nephew plc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Most Recent News
Halper Sadeh LLC probes fairness of major company sales for shareholders' benefit.
Halper Sadeh LLC is investigating whether shareholders of Arcosa, Bio-Techne, Iridium Communications, and LCI Industries are receiving fair deals in their companies' recent sales. The law firm suspects insiders may gain financial benefits not availab...

Europe approves TEPKINLY combo for relapsed follicular lymphoma, offering a chemo-free treatment option.
The European Commission has approved TEPKINLY (epcoritamab) combined with lenalidomide and rituximab for treating relapsed or refractory follicular lymphoma in adults. This marks the first bispecific antibody-based therapy authorized in Europe for se...

Class action deadlines approach for investors in BTGO, VIA, Z, and ADMA over alleged securities fraud.
Law Offices of Howard G. Smith has announced upcoming deadlines for investors to file lead plaintiff motions in class action lawsuits against BitGo Holdings, Via Transportation, Zillow Group, and ADMA Biologics. These lawsuits allege that the compani...
